{"id":"atb-1011","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4211107","moleculeType":"Small molecule","molecularWeight":"365.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an investigational autotelic biologic from Autotelicbio, ATB-1011 is engineered to leverage self-sustaining or self-directed immune mechanisms. The precise molecular basis remains proprietary, but the approach typically involves engineering biologics that can autonomously regulate their own activity or persistence in response to disease microenvironments.","oneSentence":"ATB-1011 is an autotelic biologic designed to modulate immune tolerance and promote self-directed therapeutic activity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:49.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05017987","phase":"PHASE1","title":"Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012","status":"COMPLETED","sponsor":"Autotelicbio","startDate":"2021-06-19","conditions":"Healthy Adult Volunteers","enrollment":36},{"nctId":"NCT05573477","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes","status":"UNKNOWN","sponsor":"Autotelicbio","startDate":"2022-11-16","conditions":"Essential Hypertension, Diabetes Mellitus, Type 2","enrollment":248},{"nctId":"NCT04856969","phase":"PHASE1","title":"Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Autotelicbio","startDate":"2021-03-30","conditions":"Healthy Adult Volunteers","enrollment":38}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ATB-1011","genericName":"ATB-1011","companyName":"Autotelicbio","companyId":"autotelicbio","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}